personlized genomics Tag

After the sequencing of the human genome a decade ago, hopes of massive discoveries of new drugs to treat all types of diseases fell short. Now, a partnership between an up-and-coming biotechnology company, Regeneron, and the Geisinger Health System in Pennsylvania is generating new hope and a great deal of excitement, with their plans to...

The ability to understand current health conditions and to learn what others might develop down the road is one of the biggest reasons that some people are getting excited about personalized genomics. Although genome sequencing isn’t anything new, making it available on a personal level is. At a cost that currently falls just below $10,000,...